High-resolution whole-genome association study of Parkinson disease.

We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, we individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms (SNPs) in 443 sibling pairs discordant for PD. For tier 2a, we individually genotyped 1,793 PD-associated SNPs (P<.01 in tier 1) and 300 genomic control SNPs in 332 matched case-unrelated control pairs. We identified 11 SNPs that were associated with PD (P<.01) in both tier 1 and tier 2 samples and had the same direction of effect. For these SNPs, we combined data from the case-unaffected sibling pair (tier 1) and case-unrelated control pair (tier 2) samples and employed a liberalization of the sibling transmission/disequilibrium test to calculate odds ratios, 95% confidence intervals, and P values. A SNP within the semaphorin 5A gene (SEMA5A) had the lowest combined P value (P=7.62 x 10(-6)). The protein encoded by this gene plays an important role in neurogenesis and in neuronal apoptosis, which is consistent with existing hypotheses regarding PD pathogenesis. A second SNP tagged the PARK11 late-onset PD susceptibility locus (P=1.70 x 10(-5)). In tier 2b, we also selected for genotyping additional SNPs that were borderline significant (P<.05) in tier 1 but that tested a priori biological and genetic hypotheses regarding susceptibility to PD (n=941 SNPs). In analysis of the combined tier 1 and tier 2b data, the two SNPs with the lowest P values (P=9.07 x 10(-6); P=2.96 x 10(-5)) tagged the PARK10 late-onset PD susceptibility locus. Independent replication across populations will clarify the role of the genomic loci tagged by these SNPs in conferring PD susceptibility.

[1]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[2]  A. Barzilai,et al.  The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. , 2000, Journal of neural transmission. Supplementum.

[3]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[4]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[5]  J. Pritchard,et al.  Linkage disequilibrium in humans: models and data. , 2001, American journal of human genetics.

[6]  D. Maraganore,et al.  Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[7]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[8]  S. P. Fodor,et al.  Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.

[9]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[10]  M. Farrer,et al.  PARK11 is not linked with Parkinson's disease in European families , 2005, European Journal of Human Genetics.

[11]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[12]  Demetrius M Maraganore,et al.  Blood is thicker than water , 2005, Neurology.

[13]  A. Barzilai,et al.  Induction of neuronal apoptosis by Semaphorin3A-derived peptide. , 2000, Brain research. Molecular brain research.

[14]  K. Konvička,et al.  Matching strategies for genetic association studies in structured populations. , 2004, American journal of human genetics.

[15]  P. Lockhart,et al.  Functional association of the parkin gene promoter with idiopathic Parkinson's disease. , 2002, Human molecular genetics.

[16]  H. Kawano,et al.  Aberrant trajectory of ascending dopaminergic pathway in mice lacking Nkx2.1 , 2003, Experimental Neurology.

[17]  L. Seeberger,et al.  Significant linkage of Parkinson disease to chromosome 2q36-37. , 2003, American journal of human genetics.

[18]  D. Schaid,et al.  Familial aggregation of Parkinson's disease: The Mayo Clinic family study , 2004, Annals of neurology.

[19]  D. Schaid,et al.  Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.

[20]  N. Pedersen,et al.  No evidence for heritability of Parkinson disease in Swedish twins , 2004, Neurology.

[21]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[22]  K. Roeder,et al.  The power of genomic control. , 2000, American journal of human genetics.

[23]  T. Yasuhara,et al.  Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease , 2004, The European journal of neuroscience.

[24]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[25]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[26]  Fred Winston,et al.  Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene , 2004, Nature.

[27]  T. Meitinger,et al.  Multiple regions of α‐synuclein are associated with Parkinson's disease , 2005, Annals of neurology.

[28]  D. Goldstein,et al.  UCHL1 is a Parkinson's disease susceptibility gene. , 2004 .

[29]  D. Clayton,et al.  Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.

[30]  W. Tatton,et al.  Apoptosis in Parkinson's disease: Signals for neuronal degradation , 2003, Annals of neurology.

[31]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[33]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[34]  M. Farrer,et al.  Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. , 2005, Annals of neurology.

[35]  Matthew J. Farrer,et al.  α-synuclein gene haplotypes are associated with Parkinson’s disease , 2001 .

[36]  D. Cox,et al.  Complex high-resolution linkage disequilibrium and haplotype patterns of single-nucleotide polymorphisms in 2.5 Mb of sequence on human chromosome 21. , 2001, Genomics.

[37]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[38]  Hreinn Stefánsson,et al.  A susceptibility gene for late‐onset idiopathic Parkinson's disease , 2002, Annals of neurology.

[39]  Giorgio F. Gilestro,et al.  Plexin‐B3 is a functional receptor for semaphorin 5A , 2004, EMBO reports.

[40]  Kathryn Roeder,et al.  Genomic Control to the extreme , 2004, Nature Genetics.

[41]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[42]  D J Schaid,et al.  Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease. , 1998, American journal of human genetics.

[43]  Deborah A. Nickerson,et al.  Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans , 2003, Nature Genetics.

[44]  S. Kingsmore,et al.  Comprehensive human genome amplification using multiple displacement amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Kenmochi,et al.  The human mitochondrial ribosomal protein genes: mapping of 54 genes to the chromosomes and implications for human disorders. , 2001, Genomics.

[46]  J. Haines,et al.  Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. , 2001, JAMA.

[47]  E. Hirsch,et al.  Distribution of semaphorin IV in adult human brain , 1999, Brain Research.

[48]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[49]  Daniel J Schaid,et al.  Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.

[50]  A. Barzilai,et al.  Semaphorins as Mediators of Neuronal Apoptosis , 1999, Journal of neurochemistry.

[51]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[52]  J. McPherson,et al.  Molecular cloning and mapping of human semaphorin F from the Cri-du-chat candidate interval. , 1998, Biochemical and biophysical research communications.